T1	Treatment 16 67	early enteral nutrition with addition of probiotics
T2	Treatment 189 264	early enteral nutrition (EN) supplemented with probiotics (bifidobacterium)
T3	Treatment 412 437	parenteral nutrition (PN)
T4	Treatment 452 454	EN
T5	Treatment 472 503	bifidobacterium added EN (P+EN)
T6	Treatment 521 525	P+EN
T7	Treatment 589 591	EN
T8	Treatment 602 629	probiotics (bifidobacterium
T9	Treatment 755 790	anti-infection and anti-acid agents
T10	Treatment 1689 1696	in P+EN
T11	Treatment 1739 1741	in
T12	Treatment 1751 1754	and
T13	Treatment 2102 2110	P<0.01).
T14	Treatment 2143 2156	significantly
T15	Treatment 2288 2313	significant difference in
T16	Treatment 2416 2432	gastrointestinal
T17	Treatment 2604 2615	differences
T18	Treatment 2994 3001	groups.
T19	Treatment 3002 3053	CONCLUSION Our results indicated that early EN with
